Computational and artificial intelligence-based methods for antibody development
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference95 articles.
1. Top companies and drugs by sales in 2021;Urquhart;Nat. Rev. Drug Discov.,2022
2. Antibody engineering and its therapeutic applications;Kandari;Int. Rev. Immunol.,2021
3. Affinity maturation, humanization, and co-crystallization of a rabbit anti-human ROR2 monoclonal antibody for therapeutic applications;Goydel;J. Biol. Chem.,2020
4. A rapid novel strategy for screening of antibody phage libraries for production, purification, and functional characterization of amber stop codons containing single-chain antibody fragments;Perween;Biotechnol. Prog.,2021
5. DeepCPI: a deep learning-based framework for large-scale in silico drug screening;Wan;Genomics Proteomics Bioinformatics,2019
Cited by 60 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Nanopore sensing and beyond: Electrochemical systems for optically-coupled single-entity studies, stimulus-responsive gating applications, and point-of-care sensors;Sensors and Actuators Reports;2024-12
2. Emerging trends and therapeutic applications of monoclonal antibodies;Gene;2024-10
3. Guiding Diffusion Models for Antibody Sequence and Structure Co-design with Developability Properties;PRX Life;2024-09-12
4. AI-accelerated therapeutic antibody development: practical insights;Frontiers in Drug Discovery;2024-09-03
5. Next-Generation Therapeutic Antibodies for Cancer Treatment: Advancements, Applications, and Challenges;Molecular Biotechnology;2024-09-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3